首页 | 本学科首页   官方微博 | 高级检索  
检索        

局部中晚期非小细胞肺癌同步与序贯放化疗的Meta分析
引用本文:肖景榕,王捷忠,周衍,江惠娟.局部中晚期非小细胞肺癌同步与序贯放化疗的Meta分析[J].中国肿瘤临床与康复,2005,12(4):312-314.
作者姓名:肖景榕  王捷忠  周衍  江惠娟
作者单位:福建省肿瘤医院,福州,350014
基金项目:福建省肿瘤医院院内资助项目
摘    要:目的评价局部中晚期非小细胞肺癌同步与序贯放化疗的疗效.方法采用Meta分析方法收集局部中晚期非小细胞肺癌同步与序贯放化疗比较的相关文献进行综合评价.结果局部中晚期非小细胞肺癌同步与序贯放化疗的有效率与1年生存率合并率差95%可信区间分别为0.0855~0.2145和0.0122~0.1522.结论局部中晚期非小细胞肺癌同步放化疗的有效率与1年生存率优于序贯放化疗.

关 键 词:肺肿瘤/放射疗法  肺肿瘤/化学疗法  Meta分析
文章编号:1005-8664(2005)04-0312-03
修稿时间:2004年10月29

Meta-analysis of concurrent versus sequential chemo-radiotherapy in locally advanced non-small cell lung cancer
XIAO Jing-rong,WANG Jie-zhong,ZHOU Yan,et al.Meta-analysis of concurrent versus sequential chemo-radiotherapy in locally advanced non-small cell lung cancer[J].Chinese Journal of Clinical Oncology and Rehabilitation,2005,12(4):312-314.
Authors:XIAO Jing-rong  WANG Jie-zhong  ZHOU Yan  
Abstract:Objective To evaluate the efficacy of concurrent versus sequential chemo-radiotherapy in treatment of locally advanced non-small cell lung cancer(NSCLC).Methods Meta-analysis method was used to analyze the comparative efficacy of concurrent versus sequential chemo-radiotherapy in treatment of localy advanced NSCLC.Results The results showed that the 95% confidence interval of integrated RD of the response rate and 1-year survival rate between treatment with concurrent and sequential chemo-radiotherapy are 0.0855-0.2145 and(0.0122-)0.1522,respectively.Conclusion The response rate and 1-year survival rate after the concurrent chemo-radiotherapy were better than those after the sequential chemo-radiotherapy.
Keywords:Lung neoplasms/chemotherapy  Lung neoplasms/radiotherapy  Meta-analysis
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号